232 related articles for article (PubMed ID: 23799213)
21. Plasma Pentraxin 3 Differentiates Nonalcoholic Steatohepatitis (NASH) from Non-NASH.
Boga S; Koksal AR; Alkim H; Yilmaz Ozguven MB; Bayram M; Ergun M; Sisman G; Tekin Neijmann S; Alkim C
Metab Syndr Relat Disord; 2015 Nov; 13(9):393-9. PubMed ID: 26367098
[TBL] [Abstract][Full Text] [Related]
22. Are simple noninvasive scoring systems for fibrosis reliable in patients with NAFLD and normal ALT levels?
McPherson S; Anstee QM; Henderson E; Day CP; Burt AD
Eur J Gastroenterol Hepatol; 2013 Jun; 25(6):652-8. PubMed ID: 23325287
[TBL] [Abstract][Full Text] [Related]
23. Noninvasive estimation of disease activity and liver fibrosis in nonalcoholic fatty liver disease using anthropometric and biochemical characteristics, including insulin, insulin resistance, and 13C-methionine breath test.
Korkmaz H; Unler GK; Gokturk HS; Schmidt WE; Kebapcilar L
Eur J Gastroenterol Hepatol; 2015 Oct; 27(10):1137-43. PubMed ID: 26049707
[TBL] [Abstract][Full Text] [Related]
24. Clinical model for distinguishing nonalcoholic steatohepatitis from simple steatosis in patients with nonalcoholic fatty liver disease.
Palekar NA; Naus R; Larson SP; Ward J; Harrison SA
Liver Int; 2006 Mar; 26(2):151-6. PubMed ID: 16448452
[TBL] [Abstract][Full Text] [Related]
25. 13C-methacetin breath test: isotope-selective nondispersive infrared spectrometry in comparison to isotope ratio mass spectrometry in volunteers and patients with liver cirrhosis.
Adamek RJ; Goetze O; Boedeker C; Pfaffenbach B; Luypaerts A; Geypens B
Z Gastroenterol; 1999 Dec; 37(12):1139-43. PubMed ID: 10666836
[TBL] [Abstract][Full Text] [Related]
26. Complex non-invasive fibrosis models are more accurate than simple models in non-alcoholic fatty liver disease.
Adams LA; George J; Bugianesi E; Rossi E; De Boer WB; van der Poorten D; Ching HL; Bulsara M; Jeffrey GP
J Gastroenterol Hepatol; 2011 Oct; 26(10):1536-43. PubMed ID: 21950746
[TBL] [Abstract][Full Text] [Related]
27. Serum gamma-glutamyltranspeptidase distinguishes non-alcoholic fatty liver disease at high risk.
Tahan V; Canbakan B; Balci H; Dane F; Akin H; Can G; Hatemi I; Olgac V; Sonsuz A; Ozbay G; Yurdakul I; Senturk H
Hepatogastroenterology; 2008; 55(85):1433-8. PubMed ID: 18795706
[TBL] [Abstract][Full Text] [Related]
28. Combined paediatric NAFLD fibrosis index and transient elastography to predict clinically significant fibrosis in children with fatty liver disease.
Alkhouri N; Sedki E; Alisi A; Lopez R; Pinzani M; Feldstein AE; Nobili V
Liver Int; 2013 Jan; 33(1):79-85. PubMed ID: 23146095
[TBL] [Abstract][Full Text] [Related]
29. ¹³C-methacetin breath test in the evaluation of disease severity in patients with liver cirrhosis.
Vranova J; Hendrichova M; Kolarova H; Kratka K; Rosina J; Horak J
Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2013 Dec; 157(4):392-400. PubMed ID: 23549507
[TBL] [Abstract][Full Text] [Related]
30. Noninvasive assessment of nonalcoholic fatty liver disease in obese or overweight patients.
Francque SM; Verrijken A; Mertens I; Hubens G; Van Marck E; Pelckmans P; Michielsen P; Van Gaal L
Clin Gastroenterol Hepatol; 2012 Oct; 10(10):1162-8; quiz e87. PubMed ID: 22796457
[TBL] [Abstract][Full Text] [Related]
31. [The value of studying liver function reserve in hepatic carcinoma by 13C-methacetin breath test].
Li HX; Wang JP; Yang Y; Zhang J; Feng QL
Zhonghua Nei Ke Za Zhi; 2009 May; 48(5):383-7. PubMed ID: 19615155
[TBL] [Abstract][Full Text] [Related]
32. Neutrophil to lymphocyte ratio: a new marker for predicting steatohepatitis and fibrosis in patients with nonalcoholic fatty liver disease.
Alkhouri N; Morris-Stiff G; Campbell C; Lopez R; Tamimi TA; Yerian L; Zein NN; Feldstein AE
Liver Int; 2012 Feb; 32(2):297-302. PubMed ID: 22097893
[TBL] [Abstract][Full Text] [Related]
33. Increased serum soluble lectin-like oxidized low-density lipoprotein receptor-1 levels in patients with biopsy-proven nonalcoholic fatty liver disease.
Ozturk O; Colak Y; Senates E; Yilmaz Y; Ulasoglu C; Doganay L; Ozkanli S; Oltulu YM; Coskunpinar E; Tuncer I
World J Gastroenterol; 2015 Jul; 21(26):8096-102. PubMed ID: 26185381
[TBL] [Abstract][Full Text] [Related]
34. Noninvasive assessment of liver fibrosis by measurement of stiffness in patients with nonalcoholic fatty liver disease (NAFLD).
Yoneda M; Yoneda M; Mawatari H; Fujita K; Endo H; Iida H; Nozaki Y; Yonemitsu K; Higurashi T; Takahashi H; Kobayashi N; Kirikoshi H; Abe Y; Inamori M; Kubota K; Saito S; Tamano M; Hiraishi H; Maeyama S; Yamaguchi N; Togo S; Nakajima A
Dig Liver Dis; 2008 May; 40(5):371-8. PubMed ID: 18083083
[TBL] [Abstract][Full Text] [Related]
35. Comparison of NAFLD fibrosis score and BARD score in predicting fibrosis in nonalcoholic fatty liver disease.
Ruffillo G; Fassio E; Alvarez E; Landeira G; Longo C; Domínguez N; Gualano G
J Hepatol; 2011 Jan; 54(1):160-3. PubMed ID: 20934232
[TBL] [Abstract][Full Text] [Related]
36. A Comparison of
Fierbinteanu-Braticevici C; Enciu VT; Calin-Necula AM; Papacocea IR; Moldoveanu AC
J Clin Med; 2023 Mar; 12(6):. PubMed ID: 36983160
[TBL] [Abstract][Full Text] [Related]
37. Evaluation of the 13C-methacetin breath test for quantitative liver function testing.
Klatt S; Taut C; Mayer D; Adler G; Beckh K
Z Gastroenterol; 1997 Aug; 35(8):609-14. PubMed ID: 9297776
[TBL] [Abstract][Full Text] [Related]
38. Diagnosis of fibrosis and cirrhosis using liver stiffness measurement in nonalcoholic fatty liver disease.
Wong VW; Vergniol J; Wong GL; Foucher J; Chan HL; Le Bail B; Choi PC; Kowo M; Chan AW; Merrouche W; Sung JJ; de Lédinghen V
Hepatology; 2010 Feb; 51(2):454-62. PubMed ID: 20101745
[TBL] [Abstract][Full Text] [Related]
39. The non-invasive (13)C-methionine breath test detects hepatic mitochondrial dysfunction as a marker of disease activity in non-alcoholic steatohepatitis.
Banasch M; Ellrichmann M; Tannapfel A; Schmidt WE; Goetze O
Eur J Med Res; 2011 Jun; 16(6):258-64. PubMed ID: 21810560
[TBL] [Abstract][Full Text] [Related]
40. Pathologic criteria for nonalcoholic steatohepatitis: interprotocol agreement and ability to predict liver-related mortality.
Younossi ZM; Stepanova M; Rafiq N; Makhlouf H; Younoszai Z; Agrawal R; Goodman Z
Hepatology; 2011 Jun; 53(6):1874-82. PubMed ID: 21360720
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
